Unique ID issued by UMIN | UMIN000031097 |
---|---|
Receipt number | R000035516 |
Scientific Title | Surgical reconstruction using the human dried amnion of the otolaryngology region |
Date of disclosure of the study information | 2018/02/08 |
Last modified on | 2019/08/06 10:59:27 |
Surgical reconstruction using the human dried amnion of the otolaryngology region
Surgical reconstruction using the human dried amnion of the otolaryngology region
Surgical reconstruction using the human dried amnion of the otolaryngology region
Surgical reconstruction using the human dried amnion of the otolaryngology region
Japan |
The patients with the mucosa defect of the otolaryngology region receiving surgical treatment
Oto-rhino-laryngology |
Others
NO
It is a purpose that a safe, effective therapy is established by using the dried amnion as filling materials to the mucosa defect in the otolaryngology region.
Safety,Efficacy
Day to Epithelization completion after treatment
(The epithelization completion defines "the point in time when the summation of each item score became 0" as "epithelization completion" at each evaluation point of "pain, otorrhea, adhesion, color, the neovascularisation".)
1)Pain
2)otorrhea
3)adhesion
4)color
5)neovascularisation
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Device,equipment |
Dried amnion are returned by a saline (or it is the same state) and the affected part are covered by the amnion.
20 | years-old | <= |
Not applicable |
Male and Female
1) The patients of (at the agreement acquisition) 20 years old or older age
2) The patients who relatively have good overall status
3) The patients who is judged to be available for observation, the testing that conformed to a study enforcement plan and a survey
1) The person who judged a doctor to have difficulty in hospital visiting and coming home safely for study period
2) The patients who complicate infection with the activity
3) The patients who plan the enforcement of the operation for the evaluation department effective during study period in (perform a study of the agreement acquisition with starting)
4) For the group medicine of the planned drug (Xylocaine anesthetic agent, Achromycin) to use during study period, is the patients with a history of the drug allergy
5) The patients (saying that, however, the subjects who do not receive the study drug are possible) who participated in other studies or clinical studies within six months
6) Pregnancy or the childbearing patients who may be pregnant or hope for pregnancy during study period or do not use appropriate contraception
7) The patients who judged a doctor to be inadequate as an object of this study in testing at agreement acquisition
150
1st name | Shojyaku |
Middle name | |
Last name | Hideo |
University of Toyama
Dept. of Otolaryngology
930-0194
Sugitani 2630, Toyama City
076-434-7368
hshojaku@med.u-toyama.ac.jp
1st name | Shojyaku |
Middle name | |
Last name | Hideo |
University of Toyama
Dept. of Otolaryngology
930-0194
Sugitani 2630, Toyama City
076-434-7367
hshojaku@med.u-toyama.ac.jp
University of Toyama
University of Toyama
Self funding
Miyagi Cancer Center
Miyagi Cancer Center
Ethics Committee, University of Toyama
Sugitani2630, Toyama City
076-434-7145
kanakada@med.u-toyama.ac.jp
NO
2018 | Year | 02 | Month | 08 | Day |
Partially published
Terminated
2008 | Year | 02 | Month | 15 | Day |
2008 | Year | 02 | Month | 15 | Day |
2008 | Year | 02 | Month | 15 | Day |
2019 | Year | 03 | Month | 31 | Day |
2018 | Year | 02 | Month | 01 | Day |
2019 | Year | 08 | Month | 06 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035516